Dimerix Ex-Chair’s Options Face Earlier Exercise Deadline After Retirement
DXB: $0.210 +5.00% · MC: $120M
Former Dimerix director Mark Diamond holds 500,000 unlisted options, which may now be exercised by 30 October 2027 following his retirement; any options not exercised by then will lapse. The notice follows Dimerix’s recent report of a stronger cash position and progress in its clinical programs.

Comments